🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Stage 1 Hypertension

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) NCT07290244Phase 14 sites📍 Glendale📍 Boston📍 New York Life Biosciences Inc. · Tests: ER-100 epigenetic therapy SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population NCT07051603Phase 11 site📍 Guangzhou Shenzhen Salubris Pharmaceuticals Co., Ltd. · Tests: SAL0140, SAL0140 placebo A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage NCT07770685Phase 1, Phase 21 site📍 Boston Astellas Pharma Global Development, Inc. · Tests: ASP2767, Sham ASP2767, Prophylactic Regimen A, Prophylactic Regimen B, Placebo for prophylactic regimen VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population NCT07254481Phase 12 sites📍 Hangzhou📍 Shanghai Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Tests: VB19055, VB19055 placebo A Trial of "APL-9796'' in Adults With Pulmonary Hypertension NCT06846554Phase 26 sites📍 London📍 Bath📍 Cambridge Apollo Therapeutics Ltd · Tests: APL-9796, APL-9796 A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032) NCT07646860Phase 23 sites📍 Izumi📍 Suita📍 Setagaya City Merck Sharp & Dohme LLC · Tests: Sotatercept Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension NCT06823947Phase 13 sites📍 Hakata📍 Yodogawa📍 Minato-ku Kyowa Kirin Co., Ltd. · Tests: Placebo, KK3910 Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension NCT07803835Phase 11 site📍 Nanjing Shanghai Minwei Biotechnology Co., Ltd · Tests: MWX401 1, MWX401 2, MWX401 3, MWX401 4, MWX401 5 Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) NCT05587712Phase 235 sites📍 Los Angeles📍 Palo Alto📍 San Francisco Merck Sharp & Dohme LLC · Tests: Sotatercept Study of Intravenous ZMA001 in Healthy Subjects NCT05967299Phase 11 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: Placebo Cohort 1 (1.5 mg/kg/dose) only, ZMA001 (BC-NKA-20008) DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia NCT07623525Phase 1, Phase 211 sites📍 Camperdown📍 Randwick📍 Herston Diagonal Therapeutics, Inc. · Tests: DIAG723, Placebo External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial NCT05889650NA6 sites📍 Gainesville📍 Kansas City📍 Dallas Brain Trauma Foundation · Tests: External Lumbar drainage Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project NCT05989581Phase 11 site📍 Birmingham University of Alabama at Birmingham · Tests: Labetalol or Nifedipine Renal Denervation in Patients With Atrial Fibrillation and Hypertension NCT07893821NA1 site📍 London Pavel Antiperovitch · Tests: Catheter-based renal artery electrical stimulation (as a feasibility assessment for renal denervation) A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) NCT07428473Phase 13 sites📍 Clayton📍 Papatoetoe📍 Christchurch Monash University · Tests: STX-1150 Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults NCT06429930Phase 11 site📍 Christchurch Pharmosa Biopharm Inc. · Tests: L608 Liposomal inhalation suspension, Placebo Solution Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension NCT07515599n/a1 site📍 Seoul Daewoong Pharmaceutical Co. LTD. A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension NCT07758634Phase 1, Phase 22 sites📍 Port Orange📍 Melbourne CRISPR Therapeutics AG · Tests: CTX340, Placebo REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension NCT07675824Phase 1, Phase 21 site📍 Deerfield Beach Regeneron Pharmaceuticals · Tests: REGN22530
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy